REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Enzyme Or Coenzyme Containing Enzyme Or Coenzyme ContainingEnzyme Or Coenzyme Containing patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/09/07 - 20070184041 - Methods and compositions related to production of coenzyme q10 Disclosed are methods, compounds, and compositions related to the production of coenzyme Q. ... 08/09/07 - 20070184040 - Compositions for delivery of coenzyme q10 The present invention pertains to the beneficial fusibility of ubiquinone (CoQ10) into digestible carrier fats that are solid at room temperature. By melting the CoQ10 into a properly chosen digestible carrier fat(s), recrystallization and phase separation issues are solved and a substrate is supplied for improved action upon CoQ10 by ... 07/26/07 - 20070172468 - Dietary supplements for reducing cholesterol levels The disclosure is generally directed to methods and compositions for reducing blood cholesterol levels, and more particularly to dietary supplements for reducing blood cholesterol levels. The dietary supplements for reducing cholesterol typically comprise at least one phytosterol source, at least one soluble fiber source, at least one guggulsterone source, and ... 07/12/07 - 20070160591 - Peri-operative and peri-procedure nutritional supplementation The invention provides a nutritional supplement system and program for patients undergoing or who have undergone a surgical or other invasive or stressful procedure, or who have suffered an injury. This nutritional supplement for the peri-operative period is designed to prevent deficiencies of nutrients needed for optimal health and healing ... 07/12/07 - 20070160590 - Metabolic uncoupling therapy A combination of chemical agents reduces reductive stress by limiting the accumulation of high-energy electrons potentially available to the electron transport chain. A method of metabolic uncoupling therapy comprises: analyzing a specific physiologic process involving reductive stress; identifying a plurality of MUT agents that modulate metabolic pathways by influencing electron ... 05/31/07 - 20070122400 - Composition having liver function protecting effect The present invention provides a highly safe composition which is effective for protecting liver functions and preventing liver dysfunctions in the case where liver dysfunctions rise by various causes. The present inventors found that oxidized coenzyme Q is effective for protecting liver functions in the absence of selenium and that ... 05/31/07 - 20070122399 - Composition and method for facilitating bone healing The present invention provides a nutritional composition effective in facilitating bone healing in human, comprising lysine, proline, ascorbic acid, copper, vitamin B6. The nutritional composition contains 27-34% wt lysine, 14-16% wt proline, and 42-47% wt ascorbic acid. The nutritional composition further comprises vitamin A, vitamin D3, vitamin E, vitamin B1, ... 05/10/07 - 20070104701 - Method for stabilizing reduced coenzyme q10 Reduced coenzyme Q10, which is readily oxidized in the air, is stabilized by causing ascorbic acid or a related compound thereof to coexist with a polyglycerol fatty acid ester with a polymerization degree of glycerol being not lower than 3 and/or a condensed ricinoleic acid polyglyceride in a mixture of ... 05/03/07 - 20070098706 - Nadph oxidase cytosolic cofactor mutant A purified polypeptide includes an NADPH oxidase cytosolic cofactor polypeptide NOXA1 or P67phox having a C-terminal SH3 domain insertion mutation of at least three consecutive amino acids positioned between PEDL and GIFPK motifs of said SH3 domain so as to reduce activity of the purified polypeptide relative to the wild-type ... 03/29/07 - 20070071740 - Purified amniotic membrane compositions and methods of use Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from ... 03/08/07 - 20070053893 - Method of reducing immunological tolerance to malignancy Disclosed are therapeutic formulations comprising myristoylCoA and N-myristoyl transferase and methods of using such formulations to stimulate the immune system of a mammal afflicted with carcinoma and having a detectable blood level of unacylated A-protein to produce an immune response thereto. Also disclosed are methods of treating an A-protein displaying ... 03/08/07 - 20070053892 - Methods and kits for co-administration of nutritional supplements The present invention relates to methods of co-administration of various vitamin, mineral and aspirin compositions, and in a specific embodiment, comprise co-administering one composition comprising vitamin B6, vitamin B12, folic acid, and CoQ10 and a second composition comprising aspirin for nutritional supplementation and drug therapy in order to prevent, treat ... 03/01/07 - 20070048296 - Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation The invention provides methods and compositions that include a nutraceutical supplement, antibiotic, and metal chelating agent that is administered to a patient to treat or prevent pathological calcification and or plaque formation as associated with Nanobacteria Calcifying Nano-Particles and/or diseases caused there-from, The method includes the administration of a therapeutically ... 02/22/07 - 20070041958 - Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the enzyme peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the enzyme peptides, and methods of identifying ... 02/08/07 - 20070031394 - Method of treating neurological disorders Essential tremor can effectively be treated with high doses of Riboflavin (vitamin B2), either on its own or coupled with one or more other B vitamins and/or coenzyme Q10 (CoQ10). The treatment constitutes a significant improvement over prior treatment methods in that it not only alleviates essential tremor, but results ... 02/01/07 - 20070025976 - Process for the purification of coenzyme q10 The present invention relates to methods for purifying Coenzyme Q10. ... 01/25/07 - 20070020251 - Paralytic peptide for use in neuromuscular therapy The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide. ... 01/11/07 - 20070009504 - Pro-apoptotic agents A substantially pure excretory-secretory product is isolatable from Necator americanus and is capable of inducing apoptosis in reactive T cells. ... 12/28/06 - 20060292135 - Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl A composition and method for treating bacterial infections by the use of an effective amount of at least one lytic specific for the bacteria causing specific. The lytic enzyme is genetically coded for by a bacteriophage which may be specific for said bacteria. The enzyme may be at least one ... 12/28/06 - 20060292134 - Composition for enhancing cellular energy A composition for enhancing cellular energy that includes creatine, L-arginine-α-ketoglutarate, D-ribose, L-carnitine, L-citrulline, and pyruvate. The composition is administering to a subject to enhance cellular energy, to increase relative intensity of physical activity performed by the subject, to increase endurance of the subject during the physical activity and to increase ... 11/30/06 - 20060269535 - Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy Formulations are provided for the trigger and release of bioenergy. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber and includes at least one metal-binding protein in an alkaline buffer system. The elemental complex includes one or ... 11/16/06 - 20060257385 - Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration A dietary supplement comprising Coenzyme Q10 (i.e. ubiquinone) and a bioadhesive substance is described. Derivatives of Coenzyme Q10 may also be used in the dietary supplement. The dietary supplement may be provided to an individual to increase blood plasma levels of Coenzyme Q10. ... 11/09/06 - 20060251637 - Oil-in-water type emulsion containing coenzyme q10 and process for producting the same To provide an oil-in-water emulsion composition that prevents separation of coenzyme Q10 and creaming during storage, maintains a stable emulsification state over long term exceeding two weeks, and does not impair flavor or taste. The oil phase of the oil-in-water emulsion composition contains coenzyme Q10, and a complex of an ... 10/26/06 - 20060239987 - Nutritional composition and methods of making and using same A composition and method for treatment and/or prophylaxis of stressed-induced conditions and a method of forming the composition are disclosed. The composition includes hyaluronic acid and superoxide dismutase configured to mitigate denaturing of the superoxide dismutase in a digestive track of an animal. Mitigating the denaturing of the superoxide dismutase ... 10/26/06 - 20060239986 - Method for the formation of hydrogel multilayers through surface initiated photopolymerization Multiple-layer hydrogels and methods of forming hydrogels having multiple layers are disclosed. The hydrogels are formed of prepolymerization solutions comprising monomers or macromers, particularly polyethylene glycol. The layers are covalently bonded, and the hydrogels may comprise two or more layers. ... 10/19/06 - 20060233776 - C1-inh as a drug for treating viruses pathogenic to humans The C1 esterase inhibitor (C1-INH) from human plasma is a sialic-acid-containing glycoprotein which can bind other glycoproteins and glycolipids which may be components or even membrane components of microoganisms of viral and bacterial origin. In accordance with the invention, this binding can inhibit the penetration of certain viruses into target ... 09/21/06 - 20060210546 - Athlete dietary supplement A vitamin supplement to temporarily enhance the abilities of a individual during a sport activity which includes a plurality of B family vitamins and one or more other vitamins, minerals, and/or natural ingredients. ... 09/07/06 - 20060198831 - Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality Nitrosylation of proteins and amino acid groups enables selective regulation of protein function, and also endows the proteins and amino acids with additional smooth muscle relaxant and platelet inhibitory capabilities. Thus, the invention relates to novel compounds achieved by nitrosylation of protein thiols. Such compounds include: S-nitroso-t-PA, S-nitroso-cathepsin; S-nitroso-lipoprotein; and ... 09/07/06 - 20060198830 - Ubiquinone composition and a container for its convenient transport and storage The present invention relates to a combination of a hermetically sealed, substantially air-tight container, and a quinone-containing composition disposed therein. The container of the present invention is adapted for the convenient transport, and storage of an effective amount of an active ingredient, for example, ubiquinone, ubiquinol or a mixture thereof, ... 08/31/06 - 20060193843 - Thermostable enzyme compositions The present invention relates to a composition comprising at least two thermostable enzymes selected from the group consisting of endoglucanase, xylanase, phytase, protease, galactanase, mannanase, dextranase, and alpha-galactosidase. The thermostable enzymes have a melting temperature, Tm, of at least 70° C. Preferred compositions comprise a xylanase of glycoside hydrolase family ... 08/24/06 - 20060188492 - Topical management of ocular and periocular conditions Chronic glaucoma, cataract, ocular and periocular aging are treated and prevented by the administration of agents that affect metabolic subsystems such as (i) mitochondrial bioenergetics, (ii) free radical moderation and glutathione maintenance, (iii) constitutive nitric oxide/endothelin-1 balance, and (iv) calcium wave signaling and associated neuronal excito-toxicity. Included among the agents ... 08/17/06 - 20060182729 - Combat/training antioxidant micronutrient formulation and method of administration The invention is directed to a method for administering antioxidant micronutrient formulations comprising certain multiple dietary and endogenous antioxidants, B-vitamins, vitamin D, and minerals at appropriate doses and dose-schedules, particularly chosen to reduce acute and long-term adverse effects of environmental and physical stressors and toxic chemicals in Operating Forces, e.g., ... 08/17/06 - 20060182728 - Methods for treating pervasive development disorders A method of utilizing the chymotrypsin level of an individual as a measure of the success of secretin, other neuropeptides, and peptides or digestive enzyme administration to such individuals, and in particular, as a prognosticative of potential secretin, other neuropeptides, peptides, and digestive enzyme administration for persons having ADHD, Autism ... 08/10/06 - 20060177430 - Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer An ophthalmic formulation is provided for the prevention and treatment of adverse ocular conditions, including presbyopia, arcus senilis, age-related macular degeneration, and other conditions associated with aging. The formulation is also useful in the prevention and treatment of other adverse ocular conditions such as those associated with oxidative and/or free ... 08/03/06 - 20060171937 - Method of treating chronic cardiac disease New therapeutic uses for BPI protein products that involve treatment of chronic cardiac disease. ... 07/27/06 - 20060165672 - Fatigue reducing agent To maintain physical fitness and health of middle-aged and older persons living in the threshold of the aging society, the present invention provides a fatigue reducing agent which is highly effective for preventing and reducing fatigue, wherein the agent is made of a composition of substances that are very safe ... 07/27/06 - 20060165671 - Novel nutraceutical compositions comprising epigallocatechin gallate The invention relates to nutraceutical compositions comprising at least two ingredients from the groups of EGCG, pantethine or a metabolite thereof, phytanic acid, lipoic acid, policosanol and coenzyme Q-10 and their use in the treatment or prevention of diabetes or obesity. ... 07/13/06 - 20060153824 - Methods and kits for co-administration of nutritional supplements The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, comprise co-administering one composition comprising vitamin B6, vitamin B12, folic acid, and CoQ10 and a second composition comprising omega-3 fatty acids for nutritional supplementation in order to prevent, treat and/or alleviate ... 07/13/06 - 20060153823 - Compositions and methods for nutritional supplementation The present invention relates to compositions, that may be swallowable, chewable or dissolvable, comprising various vitamins, and in a specific embodiment, comprise vitamin B6, vitamin B12, folic acid, and CoQ10, and methods for using these compositions for nutritional supplementation in order to prevent, treat and/or alleviate the occurrence or negative ... 06/29/06 - 20060140925 - Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use A composition of biochemical compounds involved in bioenergy metabolism of cells and a method of use in prevention and therapy of diseases are disclosed. ... 06/29/06 - 20060140924 - Composition and wipe for reducing viscosity of viscoelastic bodily fluids The present invention provides a topical composition for application to the perianal and/or labial areas of the skin which helps prevent viscoelastic fluids, such as menses and feces, from attaching to the skin and aids in the reducing the viscoelastic properties of the fluid so that the fluid can flow ... 06/22/06 - 20060134086 - Targeted enzymes The present invention provides targeted enzymes that bind to targets better than the corresponding pre-targeted enzymes bind the target under like conditions, methods of making targeted enzymes, methods of using targeted enzymes to treat diseases, and pharmaceutical compositions comprising targeted enzymes. ... 06/22/06 - 20060134085 - Compositions containing coenzyme q10 A coenzyme Q10-containing composition comprising a coenzyme Q10 and a hydrophilic fatty acid ester of a polyhydric alcohol; a coenzyme Q10-containing composition comprising a coenzyme Q10, a lipophilic fatty acid ester of a polyhydric alcohol and a hydrophilic fatty acid ester of a polyhydric alcohol; and a food or beverage ... 06/15/06 - 20060127384 - Coenzyme q10 as antiapoptotic agent The invention discloses the use of coenzyme Q10 for preventing or inhibiting apoptosis in cutaneous or adipose cells and tissues, and pharmaceutical compositions containing coenzyme Q10 for the treatment of transplanted tissues. ... 06/08/06 - 20060121016 - Methods and compositions for treatment of free radical injury Therapeutic methods and compositions useful for the prevention and/or treatment of cellular membrane damage leading to or resulting from peroxidation of the cellular membrane and a breakdown of the barrier function of the cellular membrane. A therapeutic composition includes a combination of a membrane sealing sealing surfactant and a cofactor ... 04/27/06 - 20060088516 - Synthetic peptide combinations and methods of producing same Preparation containing synthetic peptide combinations for application to humans or animals, wherein the peptide combinations originate from the partial hydrolysis of tissues from the human organism, wherein the peptide combinations are obtained from the neosynthesis of peptides, with the latter corresponding in their structure and composition to the tissue of ... 04/27/06 - 20060088515 - Methods and devices for sustained in-vivo release of an active agent The present invention includes methods and devices for providing sustained in-vivo release of an active agent to a subject. In some aspects, such release may be achieved by reacting an active agent in-vivo with a depot forming agent in order to form a sustained release active agent depot inside the ... 04/20/06 - 20060083730 - Method for treatment of osteochondral and bone defects using an acellular matrix implant An acellular matrix implant for treatment of defects and injuries of articular cartilage, bone or osteochondral bone and a method for treatment of injured, damaged, diseased or aged articular cartilage or bone, using the acellular matrix implant implanted into a joint cartilage lesion in situ and a bone-inducing composition implanted ... 04/20/06 - 20060083729 - Biocompatible tissue sealant for treatment of osteochondral and bone defects using an acellular matrix implant An acellular matrix implant for treatment of defects and injuries of articular cartilage, bone or osteochondral bone and a method for treatment of injured, damaged, diseased or aged articular cartilage or bone, using the acellular matrix implant implanted into a joint cartilage lesion in situ and a bone-inducing composition implanted ... 04/20/06 - 20060083728 - Acellular matrix implant for treatment of cartilage lesions, injuries and defects An acellular matrix implant for treatment of defects and injuries of articular cartilage, bone or osteochondral bone and a method for treatment of injured, damaged, diseased or aged articular cartilage or bone, using the acellular matrix implant implanted into a joint cartilage lesion in situ and a bone-inducing composition implanted ... 04/20/06 - 20060083727 - Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation The invention provides methods and compositions that include a nutraceutical supplement, antibiotic, and metal chelating agent that is administered to a patient to treat or prevent pathological calcification and or plaque formation as associated with Nanobacteria Calcifying Nano-Particles and/or diseases caused there-from, The method includes the administration of a therapeutically ... 04/13/06 - 20060078549 - Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as huntington's disease, by using coenzyme q10 A method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as Huntington's disease, includes administering a formulation including mitochondrial coenzyme Q10 in a subject in need thereof. The formulation includes Hydro-Q Sorb®, which is a complex of coenzyme Q10 and cyclodextrin. ... 04/06/06 - 20060073131 - Coenzyme q compositions persisting in blood The object of the present invention is to provide a composition maintaining a blood coenzyme Q concentration at a high level in blood for a prolonged period of time, in order to surely attain an effect of coenzyme Q, which can be expected to manifest a superior effect in maintaining ... 02/16/06 - 20060034815 - Novel statin pharmaceutical compositions and related methods of treatment The invention provides novel omega-3 oil solutions of one or more statins. These solutions are readily bioavailable. Notably, because the solutions of the invention contain an omega-3 oil as the major ingredient, they not only provide an antihypercholesterolemic effect due to the statin active ingredient, they also provide recommended daily ... 02/09/06 - 20060029587 - Peri-operative and peri-procedure nutritional supplementation The invention provides a nutritional supplement system and program for patients undergoing or who have undergone a surgical or other invasive or stressful procedure, or who have suffered an injury. This nutritional supplement for the peri-operative period is designed to prevent deficiencies of nutrients needed for optimal health and healing ... 02/09/06 - 20060029586 - Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates in which A is an active agent comprising an active hydroxy or amino functionality and B is a biopolymer comprising an active hydroxy or amino functionality, and X1 and X2 are independently N or O, and R is substituted alkyl or unsubstituted alkyl or unsubstituted or substituted heteroalkyl from 1 ... 01/26/06 - 20060018891 - Super absorption coenzyme q10 An improved soft gelatin formulation and process methodology that increases single Coenzyme Q10 molecules presented to the absorption channels of the small intestines by providing medium chain triglycerides, Vitamin E and natural beta carotene to Coenzyme Q10 in a soft gel capsule to increase the absorption thereof. ... 01/05/06 - 20060002911 - Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity The invention relates to a combination comprising one or more ligands of peroxisome proliferator activated receptors and an antioxidant agent, and to pharmaceutical compostions comprising the combination. ... 12/29/05 - 20050287131 - Health supplement The present invention relates to a health supplement that can include a number of ingredients that provide various health benefits. The supplement can be aloe vera based and include grape skin extract, grape seed extract, and/or citrus bioflavanoids. The supplement can also include a whole food component including ingredients such ... 12/22/05 - 20050281794 - Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease using a composition comprising a catechin compound, ascorbic acid, proline and lysine. ... 12/15/05 - 20050276795 - Chemotherapeutic and prophylactic pharmaceutical compositions The present invention provides pharmaceutical compositions and methods for making the same, which are highly effective against cancer, viruses, amoebae, bacteria (both gram-negative and -positive), fungi, algae, bacterial spores, yeast, and the like. The compounds preferably rely on employing the synergistic effect of organo-metal compounds and the concomitant generation of ... 11/10/05 - 20050249713 - Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q10, nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines. ... 11/03/05 - 20050244395 - Targeted enzyme prodrug therapy The present invention provides targeted enzymes that bind to targets better than the corresponding pre-targeted enzymes bind the target under like conditions, methods of making targeted enzymes, methods of using targeted enzymes to treat diseases, and pharmaceutical compositions comprising targeted enzymes. ... 10/27/05 - 20050238633 - Protease inhibition for prevention or treatment of heart failure Methods, and compositions to prevent and/or treat acute or chronic right ventricular failure from pressure over load (RVPO). In one embodiment, the method includes the inhibition of at least one cysteine protease. In other embodiments, the method includes the inhibition of MMP activity to prevent or treat right ventricular failure ... 10/20/05 - 20050232911 - Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid Compositions and methods for treating and/or preventing metabolic syndrome in a subject exhibiting clinical and/or biochemical manifestations of metabolic syndrome, or being predisposed to developing metabolic syndrome, or a precursor indicator for metabolic syndrome. The method comprises administering a pharmaceutically-effective form of carnitine or a pharmaceutically acceptable salt thereof, alone ... 10/13/05 - 20050226858 - Compositions containing reduced coenzyme q10 and carotenoid The composition includes both reduced coenzyme Q10 and a carotenoid, and the activity for removing active oxygen and/or free radicals is synergistically enhanced. A method for removing active oxygen and/or free radicals by using the composition containing both reduced coenzyme Q10 and a carotenoid is also provided. ... 09/08/05 - 20050196390 - Metalloproteinase inhibitor A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed. ... 09/08/05 - 20050196389 - Chlorella containing nutritional supplement having improved digestability A chlorella containing nutritional supplement having improved digestibility is provided. The nutritional supplement contains chlorella and an enzyme blend including select lysing enzymes effective to lyse fibrous components of the chlorella cell wall and select microbial enzymes effective to digest carbohydrate and protein components of the chlorella. The select lysing ... 08/25/05 - 20050186196 - Antioxidant combination composition and use thereof (4) coenzyme Q10; (e) Vitamin E; and (f) selenomethionine, suitable for counteracting oxidative stress and use thereof are disclosed. ... 08/25/05 - 20050186195 - Use of creatine or creatine compounds for skin preservation The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanidino benzoates as energy generating systems and antioxidants for preservation of skin against adverse aging effects and damage secondary ... 08/25/05 - 20050186194 - Use of creatine or creatine compounds for skin preservation The present invention relates to the use of creatine compounds such as, for example, creatine, creatine phosphate or analogs of creatine, such as creatine-pyruvate, creatine-ascorbate, cyclocreatine, 3 guanidinopropionic acid, guanidinoacetate, homocyclocreatine, guanidino benzoates as energy generating systems and antioxidants for preservation of skin against adverse aging effects and damage secondary ... 08/11/05 - 20050175599 - Process for producing substance The present invention relates to a process for producing a substance, which comprises culturing an animal cell having an ability to produce the substance in a medium containing a ubiquinone such as Q10 until the substance is produced and accumulated in the culture, and recovering the substance therefrom, and a ... 08/04/05 - 20050169903 - Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof The invention described herein encompasses methods of preventing or treating disorders caused by oxidative damage by an aging-specific isoform of NADH oxidase (AR—NOX). The invention encompasses methods of assaying, screening, and identifying agents that inhibit AR—NOX, as well as methods using ubiquinone to inhibit the ability of AR—NOX to generate ... 07/07/05 - 20050147598 - Method for stabilizing reduced coenzyme q10 and composition therefor The present invention relates to a method for stabilizing reduced coenzyme Q10, which is useful as an ingredient in good foods, functional nutritive foods, specific health foods, nutritional supplements, nutrients, animal drugs, drinks, feeds, cosmetics, medicines, remedies, preventive drugs, etc., and to a composition therefor. The composition comprises reduced coenzyme ... 06/30/05 - 20050142125 - Process for the preparation of protease inhibitor using novel alkalothermophilic bacillus sp The present invention relates to a novel strain of alkalothermophilic Bacillus sp. isolated from a hot spring at Vajeshwari, District Thane, The State of Maharashtra, India and deposited at American Type Culture Centre (ATCC), bearing accession No. PTA 972, said strain of Bacillus sp. having the following characteristics (i) aerobic, ... 06/30/05 - 20050142124 - Nutrient compositions and methods for enhanced effectiveness of the immune system The invention provides a nutrient composition for augmenting immune strength or physiological detoxification. The nutrient composition consists of an optimal combination of an effective amount of at least one vitamin antioxidant, at least one mineral antioxidant and a highly saturable amount of at least three high potency antioxidants. The at ... 06/30/05 - 20050142123 - Water-dispersible coenzyme q10 dry powders Novel powder compositions comprising droplets of Coenzyme Q-10 dispersed in a matrix of a modified polysaccharide or a gelatin are obtained by emulsifying Coenzyme Q-10 in a solution of the matrix components. ... 06/23/05 - 20050136043 - Tgfbeta signaling inhibitors This invention relates to peptide molecules and compounds which are negative regulators of TGFβ signaling, particularly of TβR-I kinase activity. The invention further relates to methods of using such peptides and compounds in the treatment of disease. ... 06/09/05 - 20050123528 - Application of a non-toxic organic enzyme formulation and process for reducing fungi-caused decay on fruits and vegetables There is a disclosed methods application and use of a specific enzyme formulation preventing fungi and their proteins from forming on fruits and vegetables, to extend the shelf life of the fruits and vegetables from field (pre-harvest) to packing houses, processing operations, distribution points, shippers, retailers and consumers (post-harvest). The ... 06/02/05 - 20050118153 - Antioxidant combination composition and use thereof (d) coenzyme Q10; (e) Vitamin E; and (f) selenomethionine, suitable for counteracting oxidative stress and use thereof are disclosed. ... 06/02/05 - 20050118152 - Analytical method for detecting alkaline sphingomyelinase and kit for use in such method An analytical fluorometric method and a kit for use in such method are disclosed for assessing the presence of alkaline sphingomyelinase (SMase) in the stools of a patient in need of such an assessment since alkaline SMase is a marker of serious pathological states, such as colon cancer. ... ### FreshPatents.com Support |